CIMPACT Archives - Medical Conferences

Certolizumab: Long-term safety and efficacy results for psoriasis-related nail disease

Presented By

Prof. Andrew Blauvelt, Oregon Medical Research Center, USA

Trial

Phase 3, CIMPASI

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 15:05

site created by:

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com